Abstract
Cardiovascular diseases (CVD) are related with reactive oxygen species (ROS) production and oxidative stress, including ischemia-reperfusion injury, sepsis, diabetes, and atherosclerosis. ROS originate from various sources, such as the uncoupling of nitric oxide synthase, lipoxygenase, xanthine oxidase, nicotinamide adenine dinucleotide phosphate oxidase, and particularly mitochondria. Nitric oxide synthesis impairment is a feature of endothelial dysfunction, is directly related with the development of atherosclerosis, and determines future vascular complications. In this sense, the role of oxidative stress is of great significance, although the pathways and molecular mechanisms underlying its action are not fully elucidated. This review considers the process of CVD in general and atherosclerosis in particular from a mitochondrial perspective. Although the relevance of antioxidants has been demonstrated by studies with cells and animals, their ineffectiveness in reducing cardiovascular death and morbidity in clinical trials has led many researchers to question the importance of oxidative stress in CVD. Accordingly, different approaches for the targeted delivery of antioxidants to mitochondria are being investigated. This review aims to provide a perspective of the following areas: the cellular metabolism of ROS and their role in CVD, currently available antioxidants and their prevention of oxidative stress-mediated diseases, and recent developments in mitochondria-targeted antioxidants as a weapon against mitochondrial oxidative damage and their future as a treatment for CVDs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abid MR, Schoots IG, Spokes KC, Wu SQ, Mawhinney C, Aird WC (2004) Vascular endothelial growth factor-mediated induction of manganese superoxide dismutase occurs through redox-dependent regulation of forkhead and IkappaB/NF-kappaB. J Biol Chem 279:44030–44038
Adlam VJ, Harrison JC, Porteous CM, James AM, Smith RA, Murphy MP, Sammut IA (2005) Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J 19:1088–1095
Aliev G, Seyidova D, Neal ML, Shi J, Lamb BT, Siedlak SL, Vinters HV, Head E, Perry G, Lamanna JC, Friedland RP, Cotman CW (2002) Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice. Ann N Y Acad Sci 977:45–64
Andreassi MG, Botto N (2003) DNA damage as a new emerging risk factor in atherosclerosis. Trends Cardiovasc Med 13:270–275
Apostolova N, Cervera AM, Victor VM, Cadenas S, Sanjuan-Pla A, Alvarez-Barrientos A, Esplugues JV, McCreath KJ (2006) Loss of apoptosis-inducing factor leads to an increase in reactive oxygen species, and an impairment of respiration that can be reversed by antioxidants. Cell Death Differ 13:354–357
Apostolova N, Garcia-Bou R, Hernandez-Mijares A, Herance R, Rocha M, Victor VM (2011) Mitochondrial antioxidants alleviate oxidative and nitrosative stress in a cellular model of sepsis. Pharm Res 28:2910–2919
Asimakis GK, Lick S, Patterson C (2002) Postischemic recovery of contractile function is impaired in SOD2(+/−) but not SOD1(+/−) mouse hearts. Circulation 105:981–986
Asin-Cayuela J, Manas AR, James AM, Smith RA, Murphy MP (2004) Fine-tuning the hydrophobicity of a mitochondria-targeted antioxidant. FEBS Lett 571:9–16
Ballinger SW, Patterson C, Knight-Lozano CA, Burow DL, Conklin CA, Hu Z, Reuf J, Horaist C, Lebovitz R, Hunter GC, McIntyre K, Runge MS (2002) Mitochondrial integrity and function in atherogenesis. Circulation 106:544–549
Barja G (2002) Rate of generation of oxidative stress-related damage and animal longevity. Free Radic Biol Med 33:1167–1172
Beckman KB, Ames BN (1998) The free radical theory of aging matures. Physiol Rev 78:547–581
Binková B, Smerhovský Z, Strejc P, Boubelík O, Stávková Z, Chvátalová I, Srám RJ (2002) DNA-adducts and atherosclerosis: a study of accidental and sudden death males in the Czech Republic. Mutat Res 501:115–28
Blanc J, Alves-Guerra MC, Esposito B, Rousset S, Gourdy P, Ricquier D, Tedgui A, Miroux B, Mallat Z (2003) Protective role of uncoupling protein 2 in atherosclerosis. Circulation 107:388–390
Bottoni P, Giardina B, Pontoglio A, Scarà S, Scatena R (2012) Mitochondrial proteomic approaches for new potential diagnostic and prognostic biomarkers in cancer. Adv Exp Med Biol 942:423–440
Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS (2004) Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol 287:817–833
Chang JC, Kou SJ, Lin WT, Liu CS (2010) Regulatory role of mitochondria in oxidative stress and atherosclerosis. World J Cardiol 2:150–159
Chen JW, Jen SL, Lee WL, Hsu NW, Lin SJ, Ting CT, Chang MS, Wang PH (1998) Differential glucose tolerance in dipper and nondipper essential hypertension: the implications of circadian blood pressure regulation on glucose tolerance in hypertension. Diabetes Care 21:1743–1748
Chrissobolis S, Miller AA, Drummond GR, Kemp-Harper BK, Sobey CG (2011) Oxidative stress and endothelial dysfunction in cerebrovascular disease. Front Biosci 16:1733–1745
Corral-Debrinski M, Stepien G, Shoffner JM, Lott MT, Kanter K, Wallace DC (1991) Hypoxemia is associated with mitochondrial DNA damage and gene induction. Implications for cardiac disease. JAMA 266:1812–1816
Dai L, Brookes PS, Darley-Usmar VM, Anderson PG (2001) Bioenergetics in cardiac hypertrophy: mitochondrial respiration as a pathological target of NO*. Am J Physiol Heart Circ Physiol 281:H2261–H2269
Demura M, Kamo N, Kobatake Y (1987) Mitochondrial membrane potential estimated with the correction of probe binding. Biochim Biophys Acta 894:355–364
Devary Y, Rosette C, DiDonato JA, Karin M (1993) NF-kappa B activation by ultraviolet light not dependent on a nuclear signal. Science 261:1442–1445
Di Lisa F, Bernardi P (2005) Mitochondrial function and myocardial aging. A critical analysis of the role of permeability transition. Cardiovasc Res 66:222–232
Di Taranto MD, Morgante A, Bracale UM, D’Armiento FP, Porcellini M, Bracale G, Fortunato G, Salvatore F (2012) Altered expression of inflammation-related genes in human carotid atherosclerotic plaques. Atherosclerosis 220:93–101
DiMauro S, Schon EA (2003) Mitochondrial respiratory-chain diseases. N Engl J Med 348:2656–2668
Esplugues JV, Rocha M, Nuñez C, Bosca I, Ibiza S, Herance JR, Ortega A, Serrador JM, D’Ocon P, Victor VM (2006) Complex I dysfunction and tolerance to nitroglycerin: an approach based on mitochondrial-targeted antioxidants. Circ Res 99:1067–1075
Filipovska A, Kelso GF, Brown SE, Beer SM, Smith RA, Murphy MP (2005) Synthesis and characterization of a triphenylphosphonium-conjugated peroxidase mimetic. Insights into the interaction of ebselen with mitochondria. J Biol Chem 280:24113–24126
Frei B, Kim MC, Ames BN (1990) Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proc Natl Acad Sci USA 87:4879–4883
Fridovich I (1995) Superoxide radical and superoxide dismutases. Annu Rev Biochem 64:97–112
Galley HF (2010) Bench-to-bedside review: targeting antioxidants to mitochondria in sepsis. Crit Care 14:230
Garcia-Bou R, Rocha M, Apostolova N, Herance R, Hernandez-Mijares A, Victor VM (2012) Evidence for a relationship between mitochondrial complex I activity and mitochondrial aldehyde dehydrogenase during nitroglycerin tolerance: effects of mitochondrial antioxidants. Biochim Biophys Acta 1817:828–837
Greaves LC, Reeve AK, Taylor RW, Turnbull DM (2012) Mitochondrial DNA and disease. J Pathol 226:274–286
Green D, Kroemer G (1998) The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol 8:267–271
Gutierrez J, Ballinger SW, Darley-Usmar VM, Landar A (2006) Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells. Circ Res 99:924–932
Gutteridge JM (1995) Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 41:1819–1828
Gutteridge JM, Mitchell J (1999) Redox imbalance in the critically ill. Br Med Bull 55:49–75
Hagen T, Taylor CT, Lam F, Moncada S (2003) Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha. Science 302:1975–1978
Halliwell B (1997) Antioxidants: the basics – what they are and how to evaluate them. Adv Pharmacol 38:3–20
Hernandez-Mijares A, Rocha M, Apostolova N, Borras C, Jover A, Bañuls C, Sola E, Victor VM (2011) Mitochondrial complex I impairment in leukocytes from type 2 diabetic patients. Free Radic Biol Med 50:1215–1221
Houstek J, Pícková A, Vojtísková A, Mrácek T, Pecina P, Jesina P (2006) Mitochondrial diseases and genetic defects of ATP synthase. Biochim Biophys Acta 1757:1400–1405
Hughes G, Murphy MP, Ledgerwood EC (2005) Mitochondrial reactive oxygen species regulate the temporal activation of nuclear factor kappaB to modulate tumour necrosis factor-induced apoptosis: evidence from mitochondria-targeted antioxidants. Biochem J 389:83–89
James AM, Cochemé HM, Murphy MP (2005) Mitochondria-targeted redox probes as tools in the study of oxidative damage and ageing. Mech Ageing Dev 126:982–986
Kagan VE, Serbinova EA, Stoyanovsky DA, Khwaja S, Packer L (1994) Assay of ubiquinones and ubiquinols as antioxidants. Methods Enzymol 234:343–354
Kalivendi SV, Konorev EA, Cunningham S, Vanamala SK, Kaji EH, Joseph J, Kalyanaraman B (2005) Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium. Biochem J 389:527–539
Karamanlidis G, Bautista-Hernandez V, Fynn-Thompson F, Del Nido P, Tian R (2011) Impaired mitochondrial biogenesis precedes heart failure in right ventricular hypertrophy in congenital heart disease. Circ Heart Fail 4:707–713
Kelso GF, Porteous CM, Coulter CV, Hughes G, Porteous WK, Ledgerwood EC, Smith RA, Murphy MP (2001) Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J Biol Chem 276:4588–4596
Kelso GF, Porteous CM, Hughes G, Ledgerwood EC, Gane AM, Smith RA, Murphy MP (2002) Prevention of mitochondrial oxidative damage using targeted antioxidants. Ann N Y Acad Sci 959:263–274
Knight-Lozano CA, Young CG, Burow DL, Hu ZY, Uyeminami D, Pinkerton KE, Ischiropoulos H, Ballinger SW (2002) Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues. Circulation 105:849–854
Kowaltowski AJ, Vercesi AE (1999) Mitochondrial damage induced by conditions of oxidative stress. Free Radic Biol Med 26:463–471
Lebovitz RM, Zhang H, Vogel H, Cartwright J Jr, Dionne L, Lu N, Huang S, Matzuk MM (1996) Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci USA 93:9782–9787
Madamanchi NR, Vendrov A, Runge MS (2005) Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 25:29–38
Matthews RT, Yang L, Browne S, Baik M, Beal MF (1998) Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci USA 95:8892–8897
Mercer JR, Cheng KK, Figg N, Gorenne I, Mahmoudi M, Griffin J, Vidal-Puig A, Logan A, Murphy MP, Bennett M (2010) DNA damage links mitochondrial dysfunction to atherosclerosis and the metabolic syndrome. Circ Res 107:1021–1031
Mercer JR, Gray K, Figg N, Kumar S, Bennett MR (2012) The methyl xanthine caffeine inhibits DNA damage signaling and reactive species and reduces atherosclerosis in ApoE−/− Mice. Arterioscler Thromb Vasc Biol 32:2461–2467
Meydani M (2004) Vitamin E modulation of cardiovascular disease. Ann N Y Acad Sci 1031:271–279
Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E (2005) Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142:37–46
Muratovska A, Lightowlers RN, Taylor RW, Wilce JA, Murphy MP (2001) Targeting large molecules to mitochondria. Adv Drug Deliv Rev 49:189–198
Muro S, Muzykantov VR (2005) Targeting of antioxidant and anti-thrombotic drugs to endothelial cell adhesion molecules. Curr Pharm Des 11:2383–2401
Murphy MP (2008) Targeting antioxidants to mitochondria by conjugation to lipophilic cations. In: Dykens JA, Will Y (eds) Drug-induced mitochondrial dysfunction. Wiley, Hoboken
Murphy MP, Smith RA (2007) Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 47:629–656
Nakamura T, Lipton SA (2011) Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases. Cell Death Differ 18:1478–1486
Nohl H, Kozlov AV, Gille L, Staniek K (2005) Endogenous oxidant-generating systems. In: Grune T (ed) Oxidants and antioxidants defense systems, vol 2, The handbook of environmental chemistry. Springer, Berlin, pp 1–18
Núñez C, Víctor VM, Tur R, Alvarez-Barrientos A, Moncada S, Esplugues JV, D’Ocón P (2005) Discrepancies between nitroglycerin and NO-releasing drugs on mitochondrial oxygen consumption, vasoactivity, and the release of NO. Circ Res 97:1063–1069
Powers SK, Talbert EE, Adhihetty PJ (2011) Reactive oxygen and nitrogen species as intracellular signals in skeletal muscle. J Physiol 589:2129–2138
Ramachandran A, Moellering DR, Ceaser E, Shiva S, Xu J, Darley-Usmar V (2002) Inhibition of mitochondrial protein synthesis results in increased endothelial cell susceptibility to nitric oxide-induced apoptosis. Proc Natl Acad Sci USA 99:6643–6648
Reaume AG, Elliott JL, Hoffman EK, Kowall NW, Ferrante RJ, Siwek DF, Wilcox HM, Flood DG, Beal MF, Brown RH Jr, Scott RW, Snider WD (1996) Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 13:43–47
Rocha M, Apostolova N, Hernandez-Mijares A, Herance R, Victor VM (2010) Oxidative stress and endothelial dysfunction in cardiovascular disease: mitochondria-targeted therapeutics. Curr Med Chem 17:3827–3841
Ruano-Ravina A, Figueiras A, Freire-Garabal M, Barros-Dios JM (2006) Antioxidant vitamins and risk of lung cancer. Curr Pharm Des 12:599–613
Sanjuán-Pla A, Cervera AM, Apostolova N, Garcia-Bou R, Víctor VM, Murphy MP, McCreath KJ (2005) A targeted antioxidant reveals the importance of mitochondrial reactive oxygen species in the hypoxic signaling of HIF-1alpha. FEBS Lett 579:2669–2674
Saretzki G, Murphy MP, von Zglinicki T (2003) MitoQ counteracts telomere shortening and elongates lifespan of fibroblasts under mild oxidative stress. Aging Cell 2:141–143
Schächinger V, Britten MB, Zeiher AM (2000) Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101:1899–1906
Schäfer M, Schäfer C, Ewald N, Piper HM, Noll T (2003) Role of redox signaling in the autonomous proliferative response of endothelial cells to hypoxia. Circ Res 92:1010–1015
Schulze-Osthoff K, Beyaert R, Vandevoorde V, Haegeman G, Fiers W (1993) Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J 12:3095–3104
Sheu SS, Nauduri D, Anders MW (2006) Targeting antioxidants to mitochondria: a new therapeutic direction. Biochim Biophys Acta 1762:256–265
Sies H (1993) Strategies of antioxidant defense. Eur J Biochem 215:213–219
Smith RA, Murphy MP (2011) Mitochondria-targeted antioxidants as therapies. Discov Med 11:106–114
Smith RA, Porteous CM, Coulter CV, Murphy MP (1999) Selective targeting of an antioxidant to mitochondria. Eur J Biochem 263:709–716
Smith RA, Porteous CM, Gane AM, Murphy MP (2003) Delivery of bioactive molecules to mitochondria in vivo. Proc Natl Acad Sci USA 100:5407–5412
Stavrovskaya IG, Kristal BS (2005) The powerhouse takes control of the cell: is the mitochondrial permeability transition a viable therapeutic target against neuronal dysfunction and death? Free Radic Biol Med 38:687–697
Teshima Y, Akao M, Jones SP, Marbán E (2003) Uncoupling protein-2 overexpression inhibits mitochondrial death pathway in cardiomyocytes. Circ Res 93:192–200
Thom TJ (1989) International mortality from heart disease: rates and trends. Int J Epidemiol 18:20–28
Tonkin A (2003) Atherosclerosis and heart diseases. Martin Dunitz, London, pp 1–235
Victor VM, Rocha M, De la Fuente M (2003a) N-acetylcysteine protects mice from lethal endotoxemia by regulating the redox state of immune cells. Free Radic Res 37:919–929
Víctor VM, Rocha M, De la Fuente M (2003b) Regulation of macrophage function by the antioxidant N-acetylcysteine in mouse-oxidative stress by endotoxin. Int Immunopharmacol 3:97–106
Victor VM, Rocha M, De la Fuente M (2004) Immune cells: free radicals and antioxidants in sepsis. Int Immunopharmacol 4:327–347
Victor VM, Rocha M, Esplugues JV, De la Fuente M (2005) Role of free radicals in sepsis: antioxidant therapy. Curr Pharm Des 11:3141–3158
Victor VM, Nuñez C, D’Ocón P, Taylor CT, Esplugues JV, Moncada S (2009) Regulation of oxygen distribution in tissues by endothelial nitric oxide. Circ Res 104:1178–1183
Victor VM, Rocha M, Bañuls C, Bellod L, Hernandez-Mijares A (2011a) Mitochondrial dysfunction and targeted drugs: a focus on diabetes. Curr Pharm Des 17:1986–2001
Victor VM, Rocha M, Herance R, Hernandez-Mijares A (2011b) Oxidative stress and mitochondrial dysfunction in type 2 diabetes. Curr Pharm Des 17:3947–3958
Vora DK, Fang ZT, Liva SM, Tyner TR, Parhami F, Watson AD, Drake TA, Territo MC, Berliner JA (1997) Induction of P-selectin by oxidized lipoproteins. Separate effects on synthesis and surface expression. Circ Res 80:810–818
Weissig V, Boddapati SV, D’Souza GG, Cheng SM (2004) Targeting of low- molecular weight drugs to mammalian mitochondria. Drug Des Rev 1:15–28
Yakes FM, Van Houten B (1997) Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA 94:514–519
Yan LJ, Sohal RS (1998) Mitochondrial adenine nucleotide translocase is modified oxidatively during aging. Proc Natl Acad Sci USA 95:12896–12901
Yao PM, Tabas I (2001) Free cholesterol loading of macrophages is associated with widespread mitochondrial dysfunction and activation of the mitochondrial apoptosis pathway. J Biol Chem 276:42468–42476
Zhang Y, Yuan M, Bradley KM, Dong F, Anversa P, Ren J (2012) Insulin-like growth factor 1 alleviates high-fat diet-induced myocardial contractile dysfunction: role of insulin signaling and mitochondrial function. Hypertension 59:680–693
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Victor, V.M. (2014). Reactive Oxygen Species and Atherosclerosis. In: Laher, I. (eds) Systems Biology of Free Radicals and Antioxidants. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-30018-9_53
Download citation
DOI: https://doi.org/10.1007/978-3-642-30018-9_53
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-30017-2
Online ISBN: 978-3-642-30018-9
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences